期刊文献+

Secretagogin在胃肠道类癌诊断中的作用 被引量:2

THE EFFECT OF SECRETAGOGIN ON THE DIAGNOSIS OF GASTROINTESTINAL CARCINOID
下载PDF
导出
摘要 目的探讨Secretagogin在胃肠道类癌诊断中的作用。方法采用免疫组织化学技术检测27例胃肠道类癌(6例非典型类癌)中Secretagogin、嗜铬素A(CgA)、突触素(Syn)、神经元特异性烯醇化酶(NSE)的表达,分析其表达差异性;并比较它们在典型类癌与非典型类癌中表达情况。结果胃肠道类癌组织中Secretagogin、Syn、CgA、NSE的阳性表达率分别为96.3%、100.0%、40.7%、81.5%,四者之间差异有统计学意义(χ2=23.7,P<0.01)。CgA在非典型类癌中的表达高于典型类癌(Z=-2.098,P<0.05),其余三者均无差别。结论在绝大多数胃肠道类癌组织中Secretagogin呈阳性表达,且表达程度高于CgA;Secretagogin可以作为一个新的神经内分泌标记物用于临床胃肠道类癌的诊断。 Objective To assess the value of Secretagogin in the diagnosis of gastrointestinal carcinoid. Methods The expressions of Secretagogin,synaptophysin(Syn),chromogranin A(CgA) and neuronspecific enolase(NSE) in 27 cases(six were untypical) of gastrointestinal carcinoid(GC) were detected immunohistochemically. Results The positive expression rate of Secretagogin,Syn,CgA and NSE in carcinoid was 96.3%,100.0%,40.7% and 81.5%,respectively.The differences among the four items were significant(χ^2=23.7,P0.01).CgA expression in untypical carcinoid was higher than that in typical one(Z=-2.098,P0.05),for the rest three markers,there was no significant difference among them. Conclusion Secretagogin positively expresses in the most majority of carcinoid,and its expression is stronger than that of CgA.Secretagogin can be used as a novel neuroendocrinal marker in the diagnosis of carcinoid of gastrointestinal tract.
出处 《青岛大学医学院学报》 CAS 2010年第3期258-259,262,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 胃肠道 类癌瘤 Secretagogin 嗜铬素A 突触素 磷酸丙酮酸水合酶 免疫组织化学 gastrointestinal tract carcinoid tumor Secretagogin immunohistochemisty chromogranin A synaptophysin phosphopyruvate hydratase
  • 相关文献

参考文献12

  • 1WAGNER L,OLIYARNYK O,GARTNER W,et al.Cloning and expression of secretagogin,a novel neuroendocrine-and pancreatic islet of Langerhans-specific Ca2+-binding protein[J].Biol Chem,2000,275:24740-24751.
  • 2董绍安,徐平,赵景岚.非小细胞肺癌VEGF-C和VEGFR-3表达对淋巴管生成和淋巴转移的意义[J].青岛大学医学院学报,2008,44(1):6-7. 被引量:8
  • 3吕艳华,祁秀娟.子宫内膜腺癌组织B7-H4表达及意义[J].齐鲁医学杂志,2009,24(3):221-222. 被引量:4
  • 4LAI M,L(U) B,XING X,et al.Secretagogin,a novel neuroendocrine marker,has a distinct expression pattern from chromogranin A[J].Virchows Arch,2006,449(4):402-409.
  • 5SCHER(U)BL H,GRABOWSKI P.The chromogranin-secretogranin family[J].N Engl J Med,2003,348(25):1134-1149.
  • 6WEILER R,FISCHER-COLBRIE R,SCHMID K W,et al.Immunological studies on the occurrence and properties of chromogranin A and B and secretogranin in endocrine tumours[J].Am J Surg Pathol,1988,12(11):877-884.
  • 7WILSON B S,LLOYD R V.Detection of chromogranin in neuroendocrine cells with a monoclonal antibody[J].Am J Pathol,1984,115(3):458-468.
  • 8KIMURA N,PILICHOWSKA M,OKAMOTO H,et al.Immunohistochemical expression of chromogranins A and B,prohormone convertases 2 and 3,and amidating enzyme in carcinoid tumours and pancreatic endocrine tumours[J].Mod Pathol,2000,13(2):140-146.
  • 9LOY T S,DARKOW G V,QUESENBERRY J T.Immunostaining of pulmonary neuroendocrine carcinomas.An immunohistochemical study with ultrastructural correlations[J].Am J Surg Pathol,1995,19(2):173-182.
  • 10MANI S.Carcinoids of the rectum[J].J Am Coll Surg,1994,179(2):231-248.

二级参考文献12

  • 1王中亮,陈尧,梁传余,周斌,李瑞祥,张林.VEGF-C和VEGFR-3在喉鳞状细胞癌及转移淋巴结组织中的表达[J].临床耳鼻咽喉科杂志,2004,18(11):664-667. 被引量:9
  • 2SICA G L,CHOI IH,ZHU G,et al.B7-H4,a molecule of the B7 family,negatively regulates T cell immunity[J].Immunity,2003,18(6):849-861.
  • 3TAKASHI M,BARBARA T,LIU W H,et al.B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration[J].Gynecologic Oncology,2007,106:119-127.
  • 4PRASAD D,RICHARD S,MAI X,et al.B7S1,a novel B7 family member that negatively regulate T cell activation[J].Immunity,2003,18(6):863-873.
  • 5CARRENO B M,COLLINS M.Btla:a new inhibitory recep torwith a B7 like ligand[J].Trends Immunol,2003,24(10):524-527.
  • 6TANG R F, ITAKURA J, AIKAWA T, et al. Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer[J]. Pancreas, 2001,22(3):285-292.
  • 7WEIDNER N, FOLKMAN J, POZZA F, et al. Tumorangiogenesis:a new significant and independent prognostic indicator in early-stage breast carcinoma[J]. J Natl Cancer Invst, 1992,84(24):1875-1886.
  • 8JOUKOV V, SORSA T, KUMAR V, et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C[J]. EMBO J, 1997,16(13):3898-3911.
  • 9JUSSILA L, ALITALO K. Vascular growth factors and lymphangiogenesis[J]. Physiol Rev, 2002,82(3):673-700.
  • 10SAARISTO A, PARTANEN T A, AROLA J, et al.Vascular endothelial growth factor-C and its receptor VEGFR-3 in the nasal mucosa and in nasopharyngeal tumors[J]. Am J Pathol, 2000,157(1):7-14.

共引文献10

同被引文献28

  • 1云径平,向锦,侯景辉,田秋红,符珈.CD56在小细胞癌组织中的表达及其对诊断的作用[J].癌症,2005,24(9):1140-1143. 被引量:26
  • 2SPIRA A, ETTINGER D S. Multidisciplinary management of lung cancer[J]. N Engl J Med, 2004,350(4) :379-392.
  • 3BEASLEY M B. Immunohistochemistry of pulmonary and pleural neoplasia[J]. Arch Pathol Lab Med, 2008, 132 (7) : 1062-1072.
  • 4FUJITA J, OHTSUKI Y, BANDOH S, et al. Expression of thyroid transcription factor-1 in 16 human lung cancer cell lines [J]. Lung Cancer, 2003,39 : 31-36.
  • 5FARINOLA M A, WEIR E G, ALI S Z. CD56 expression of neuroendocrine neoplasms on immunophenotyping by flow cytometry: a novel diagnostic approach to fine-needle aspiration biopsy[J]. Cancer, 2003,99(4) : 240-246.
  • 6KONTOGIANNI K, NICHOLSON A G, BUTCHER D, et al. CD56 a useful tool for lung carcinomas on biopsies with ex- tensive crush artifact [J]. Clin Pathol, 2005,58,(9):978-980.
  • 7HIROSHIMA K, IYODA A, SHIDA T, et al. Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis[J].Mod Pathol, 2006,19 : 1358-1368.
  • 8NICHOLSON S A, BEASLEY M B, BRAMBILLA E, et al. Small cell lung carcinoma (SCLC) : a clinicopathologic study of 100 cases with surgical specimens[J]. Am J Surg Pathol, 2002,26(9) : 1184-1197.
  • 9YAMAMOTO J, OHSHIMA K, IKEDA S, et al. Primary esophageal small cell carcinoma with concomitant invasive squamous cell carcinoma or carcinoma in situ[J]. Hum Pathol, 2003,34(11) : 1108-1115.
  • 10Batcher E, Madaj P,Gianoukakis AG, et al. Pancreaticneuroendocrine tumors [J]. Endocr Res,2011,36 (1) : 35-.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部